Startup Life
Technology. Startups. Venture Capital. My Life.
Technology. Startups. Venture Capital. My Life.
May 8th
A company called EnGeneIC in Sydney, Australia have created a targeted drug delivery platform based on “mini bacteria”, or as they call it, EnGeneIC Delivery Vehicles (EDVs). These vehicles look and behave like bacteria, including cell division — albeit, without chromosomes. I may need to dig a little deeper into the science of this one!
In any case, these EDVs have been shown to target tumorigenic tissue, being fed by blood vessels; 30% of an IV dosage reached the cancerous region within 2 hours. It has so far been proven safe in dogs with advanced non-Hodgkin’s lymphoma, as well as in pigs and monkeys.
The study also suggests that these EDVs can carry RNAi or siRNA-based products to their destination, as delivery of these nucleic acids has been proven difficult due to nuclease/enzymatic degredation before reaching its target.
Adapted from [NewScientist] from [Cancer Cell (vol 11, p431) "Bacterially Derived 400 nm Particles for Encapsulation and Cancer Cell Targeting of Chemotherapeutics"]
EnGeneIC,
bacteria,
EDV,
delivery vehicles,
cancer,
cell division,
chromosome,
tumorigenic,
blood vessels,
non-Hodgkin’s,
RNAi,
siRNA,
nucleic acid,
nuclease,
enzyme
Mar 21st
MIT scientists just discovered the function of 14-3-3 sigma protein, and also, what happens if it isn’t present in cells. This is a HUGE discovery toward preventative measures in cancer screening technology. It won’t be long before there are a new set of diagnostics out that screeen for a wide range of cancer precursor biomarkers that increase risk of cancer to a give tissue.
So, what do scientists propose that 14-3-3 sigma does? It plays a role in cell division. Specifically, it helps cells finish cytokinesis and separate into two distinct cells, right at the end of cell division. Michael Yaffe, an associate professor of biology and biological engineering and leader of the research team said “The cells try to divide and try to divide, and they just give up. They can’t finish cytokinesis.” This results in a single cell with two nuclei.
Key information not to be missed from the article:
The story was orginally issued by MIT, and covered by ScienceDaily under the title: MIT Identifies Role Of Key Protein In Tumor Growth
Mar 9th
If you’re a Canadian or an American, you’re in luck … mostly. In many countries internationally, namely Australia, New Zealand, England, Scotland and Denmark, many sexually transmitted infection (STI) tests came up with false negatives! Why? Because at some point, one strain of the bacteria underwent a series of mutations that has changed its expression profile for the enzyme prolyliminopeptidase (PIP) … which was the protein tested for by doctors to determine if you had an infection. If you have, or thought you got rid of your case of gonorrhoea, you might want to go back to the clinic and ask for 2 tests that check for different proteins/enzymes to ensure you got rid of your infection. For the full article see: ‘Stealth’ gonorrhoea on the rise.
To get some more information about STIs, there are many books out there that can help get you informed whether you are an average Joe, or a scientist. For the average Joe, please check out Sexually Transmitted Diseases: Colour Guide and for the scientist in you, order Sexually Transmitted Diseases.
“And remember … don’t be a fool, wrap your tool.” – Van Wilder